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Abstract: Somatic mosaicism is something that is observed in everyday lives of cytogeneticists. Chromosome instability 
is one of the leading causes of large-scale genome variation analyzable since the correct human chromosome number was 
established in 1956. Somatic mosaicism is also a well-known fact to be present in cases with small supernumerary marker 
chromosomes (sSMC), i.e. karyotypes of 47,+mar/46. In this study, the data available in the literature were collected con-
cerning the frequency mosaicism in different subgroups of patients with sSMC. Of 3124 cases with sSMC 1626 (52%) 
present with somatic mosaicism. Some groups like patients with Emanuel-, cat-eye- or i(18p)- syndrome only tend rarely 
to develop mosaicism, while in Pallister-Killian syndrome every patient is mosaic. In general, acrocentric and non-
acrocentric derived sSMCs are differently susceptible to mosaicism; non-acrocentric derived ones are hereby the less sta-
ble ones. Even though, in the overwhelming majority of the cases, somatic mosaicism does not have any detectable clini-
cal effects, there are rare cases with altered clinical outcomes due to mosaicism. This is extremely important for prenatal 
genetic counseling. Overall, as mosaicism is something to be considered in at least every second sSMC case, array-CGH 
studies cannot be offered as a screening test to reliably detect this kind of chromosomal aberration, as low level mosaic 
cases and cryptic mosaics are missed by that.  
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SMALL SUPERNUMERARY MARKER CHROMO-
SOMES (sSMC) 
  In 1956, the exact chromosomal number in humans was 
established [1]. Since then it was possible to delineate nu-
merical chromosomal aberrations in any body tissue where 
chromosomes could be prepared from, including clinical [2] 
and tumor cases [3]. After the introduction of molecular cy-
togenetics [4-7], it became even possible to analyze numeri-
cal chromosomal aberrations in non-dividing cells [8]. By 
that also low-level chromosomal aberrations could be de-
tected in tumor [9-13], various clinical [14-18] and neuronal 
diseases [19-27], embryonic tissues [28-32] and different 
tissue types [9, 13, 15, 33-35]. Overall it can be stated that 
chromosome instability is one of the main causes of large-
scale genome variation [36-39]. For review of cytogenetic 
and molecular cytogenetics see Refs. [4-5, 40].  
  Small supernumerary marker chromosomes (sSMC) are 
reported in 0.043% of newborn infants, 0.077% of prenatal 
cases, 0.433% of mentally retarded patients and 0.171% of 
subfertile people [41]. They are defined as structurally ab-
normal chromosomes that cannot be identified or character-
ized unambiguously by conventional banding cytogenetics   
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alone, and are generally equal in size or smaller than a chro- 
mosome 20 of the same metaphase spread; sSMC can either  
be present additionally in (1) an otherwise normal karyotype,  
(2) a numerically abnormal karyotype (like Turner- or   
Down-syndrome) or (3) a structurally abnormal but balanced  
karyotype with or without ring chromosome formation [42].  
sSMCs are normally detected by banding cytogenetics in   
mentally retarded patients, in subfertile persons or during   
prenatal diagnosis and particularly prenatally ascertained   
ones, are not easy to correlate with a clinical outcome. It is  
known that ~30% of sSMCs are derived from chromosome  
15; ~11% are i(12p) = Pallister-Killian, ~10% are der(22)- 
Emanuel-,~7% are inv dup (22)-cat-eye- and ~6% are i(18p)- 
syndrome associated sSMC [42]. 
  sSMC are for several reasons still a problem in clinical 
cytogenetics: (i) they are too small to be characterized for 
their chromosomal origin by traditional banding techniques 
and require molecular (cytogenetic) techniques for their 
identification [41]; (ii) apart from the correlation of about 
one-third of the sSMC cases with a specific clinical picture, 
as mentioned above, most of the sSMCs have not been corre-
lated with clinical syndromes, even though progress was 
achieved, recently [43, 44]; (iii) sSMC can be harmful due to 
different mechanisms like induction of genomic imbalance 
and/or uniparental disomy [42]; (iv) also sSMC can be found 
just by chance and cannot be correlated with the clinical 
problems of a patient [44]; finally (v) the percentage in Somatic Mosaicism in Cases with Small Supernumerary Marker  Current Genomics, 2010, Vol. 11, No. 6    433 
which an sSMC is present can, but must not have an influ-
ence on the clinical outcome [42-44].  
  Here we focus on the latter mentioned problem – the 
regularly appearing somatic mosaicism in cases with an 
sSMC.  
  Mosaicism in association with sSMC is a well-known 
fact. Crolla (1998) [45] summarized 144 sSMC cases ex-
cluding those derived from chromosomes 15 and 22, 78 of 
which (54%) showed mosaic karyotypes. To get a more de-
tailed view on mosaicism in sSMC the following subgroups 
are focused separately below: cases with sSMC duplication 
and multiple sSMC, cases with four known ‘sSMC-
syndromes’ Pallister-Killian-, i(18p)-, Emanuel-, and cat-
eye-syndrome, cases with sSMC and Prader-Willi- and An-
gelman-syndrome, cases with an sSMC present in a structur-
ally abnormal but balanced karyotype, neocentric sSMC 
cases and patients with numerically abnormal basic karyo-
types. The remaining sSMC with a normal basic karyotype 
of 46 chromosomes plus an sSMC are the group of patients 
this review starts with. 
SOMATIC MOSAICISM IN sSMC PRESENT IN A 
NORMAL BASIC KARYOTYPE  
  According to Liehr (2010) [44] 731/1512 sSMC cases 
(52%) studied by cytogenetics are mosaic (see Table 1). 
Table 1.  Cases with Mosaics 47,+mar, Excluding Cases with Known Syndromes, with Neocentric sSMC and such with Unclear 
Mosaicism Status 
sSMC derived from chromosome  Number of cases with 47,+mar[100%]  Total number of sSMC cases  Cases with mos 47,+mar/46  
1 6  67  91% 
1/5/19 0 8  100% 
2 6  36  83% 
3 7  21  67% 
4 7  21  67% 
5 10  34  71% 
6 2  14  86% 
7 5  23  78% 
8 11  92  88% 
9 4  59  93% 
10 5  18  72% 
11 3  16  81% 
12 6  29  79% 
13 7  9  22% 
13/21 54  84  36% 
14 62  99  37% 
14/22 31  49  37% 
15 361  459  21% 
16 4  46  91% 
17 6  26  77% 
18 14  43  67% 
19 7  40  83% 
20 7  33  79% 
21 12  25  83% 
22 78  115  32% 
acro 3  6  50% 
X 7  27  74% 
Y 6  13  54% 
overall 731  1512  52% 
acrocentric 608  846  28% 
non-acrocentric 123  666 82% 434    Current Genomics, 2010, Vol. 11, No. 6  Liehr et al. 
However, there is a strong difference between acrocentric 
and non-acrocentric derived sSMC: while 72% of acrocentric 
derived sSMC present no mosaic, 82% of non-acrocentric 
derived sSMCs are mosaic.  
  The real grade and complexity of mosaicism seems to be 
even slightly higher as recently repeatedly cryptic mosaicism 
was detected in sSMC cases by molecular cytogenetics. 
There were either cases showing an sSMC in all studied 
metaphase spreads, however, interphase-FISH in uncultured 
cells showed a mosaic situation like in case 16-CW-2 [44]. 
More often it is found that more than one variant of an sSMC 
is present in different studied cells of a patient. As summa-
rized in Table 2, at least 5% of sSMC cases have, after a 
detailed molecular cytogenetic analysis, a more complex 
mosaicism than suggested after simple cytogenetic diagnos-
tics. In 20% of these cases, unexpected complex somatic 
mosaicism was detectable where cytogenetics did not sug-
gest any mosaicism, i.e. in cases 04-U-7, 08-W-p11.2/1-2, 
11-O-p11.1/2-1, 11-U-9, 13-U-13, 15-W-q11.1+q11.2/1-1, 
21-O-q11.21/1-1, 21-U-5, 22-O-q11.1/5-1, 22-O-q11.1/5-2, 
0X-W-p11.?3/1-1, 0X-W-p11.21/1-1 [44]. Interestingly, 
acrocentric derived sSMC are by far more stable than non-
acrocentric derived ones (2% versus 9%, Table 2).  
  Cryptic mosaicism appears as some sSMC tend to rear-
range and/or be reduced in size during karyotypic evolution. 
This can lead to double ring formation or inverted duplica-
Table 2.  Cases with Cryptic Mosaics 47,+mar, Excluding Cases with Known Syndromes, with Neocentric sSMC and such with 
Unclear Mosaicism Status 
sSMC derived from chromosome  Number of cases with cryptic mosaicism   Number of cases with cryptic mosaicism 
1 0/67 0% 
1/5/19 0/8  0% 
2 2/36 5% 
3 5/21  24% 
4 1/21 5% 
5 5/34  15% 
6 4/14  29% 
7 4/23  17% 
8 8/92 9% 
9 6/59  10% 
10 0/18 0% 
11 4/16 25% 
12 2/29 7% 
13 2/9 15% 
13/21 0/84  0% 
14 2/99 2% 
14/22 0/49  0% 
15 4/459  1% 
16 3/46 19% 
17 0/26 0% 
18 2/43 5% 
19 6/40 15% 
20 4/33 12% 
21 2/25 8% 
22 5/115 4% 
acro 0/6  0% 
X 2/27 7% 
Y 0/13 0% 
overall 73/1512  5% 
acrocentric 15/846  2% 
non-acrocentric 58/666  9% Somatic Mosaicism in Cases with Small Supernumerary Marker  Current Genomics, 2010, Vol. 11, No. 6    435 
tion starting from a centric minute-shaped chromosome and 
in the end to the formation of different variants and a highly 
complex mosaic as some of the new variants can also be 
degraded in a subset of the studied cells [46]. 
  In summary, somatic mosaics are to be expected in at 
least 50% of sSMC cases with normal basic karyotype. More 
complex mosaics can be met in up to 10% of the cases; how-
ever, the overall rate of mosaic cases is not significantly al-
tered by cryptic mosaicism, while the genetic complexity of 
individual cases may be severely influenced. 
SOMATIC MOSAICISM IN CASES WITH sSMC DU-
PLICATION AND MULTIPLE sSMC 
  sSMC in a small subset of cases tend to duplicate, lead-
ing to a karyotype 48,+marx2 [42]. Up to now 64 such cases 
are reported [44] and 45% of those are derived from non-
acrocentric chromosomes (Table 3). While, cases with ac-
rocentric derived sSMC tend to be by mosaic only in 54% of 
the cases, non-acrocentric derived ones are always mosaic 
with an exception of 1/29 reported patients (Table 3). Thus, 
in sSMC duplication cases we find a similar situation as in 
Table 3.  Cases with Mosaics 48,+marx2 Excluding Cases with Known Syndromes, with Multiple and Neocentric sSMC and such 
with Unclear Mosaicism Status 
sSMC derived from chromosome  Number of cases with 48,+marx2[100%]  Total number of sSMC cases  Cases with mosaic 
1  n.a.  2 (diff. sizes)  100% 
1/5/19 n.a. n.a.  n.a. 
2 n.a.  2  100% 
3  n.a.  2 (diff. sizes)  100% 
4  n.a.  1 / 1 (diff. sizes)  100% 
5  n.a.  1 / 1 (diff. sizes)  100% 
6  n.a.  1 / 1 (diff. sizes)  100% 
7 n.a.  n.a.  n.a. 
8  n.a.  2 / 1 (diff. sizes)  100% 
9  n.a.  2 / 1 (diff. sizes)  100% 
10 n.a.  n.a.  n.a. 
11 n.a.  n.a.  n.a. 
12 n.a.  n.a.  n.a. 
13 1  1  0% 
13/21  1  1 / 1 (diff. sizes)  50% 
14  2  3 / 1 (diff. sizes)  50% 
14/22 1  3  67% 
15 11  22  50% 
16  n.a.  1 / 1 (diff. sizes)  100% 
17  n.a.  1 / 1 (diff. sizes)  100% 
18 n.a.  n.a.  n.a. 
19 1  1  0% 
20  n.a.  3 / 1 (diff. sizes)  100% 
21 n.a.  1  100% 
22 n.a.  2  100% 
acro n.a.  n.a.  n.a. 
X n.a.  1  100% 
Y n.a.  1  100% 
overall 17  64  73% 
acrocentric 16  35  54% 
non-acrocentric 1  29  97% 436    Current Genomics, 2010, Vol. 11, No. 6  Liehr et al. 
cases with one single sSMC and a karyotype 47, +mar con-
cerning mosaicism.  
  Multiple sSMC cases [42] differ from sSMC duplication 
ones by the fact that the observed sSMC are not derived 
from the identical chromosome. Only 48 such cases are 
known by now [44], having between 2 and 7 sSMC of dif-
ferent origin, each; and all reported cases with multiple 
sSMC are mosaic. Formation of this rare cytogenetic condi-
tion is unclear, even though polysomic rescue or triploid 
rescue maybe suggested. As in most cases markedly chro-
mosomal imbalances are induced by multiple sSMC pres-
ence, ~90-95% of them are correlated with clinical symp-
toms, irrespective of mosaicism status detectable in periph-
eral blood.  
SOMATIC MOSAICISM PRESENT IN THE FOUR 
KNOWN ‘sSMC-SYNDROMES’: PALLISTER-KILLIAN-, 
I(18P)-, EMANUEL-, AND CAT-EYE-SYNDROME 
  Somatic mosaicism is reported to different extents in four 
sSMC-related syndromes.  
  Patients suffering from Pallister-Killian-syndrome (PKS) 
due to the presence of an additional isochromosome 12p are 
known to have somatic mosaicism in practically every case. 
In peripheral blood the +(12p) tends to be lost either already 
during pregnancy or shortly after birth in practically all cells. 
In the alternatively studied skin fibroblasts, the sSMC de-
rived from chromosome 12 is normally easily to detect in 
>70% to 100% of the cells [47]. However, besides a mosaic 
of cells with 46 and 47 chromosomes exceptional cases also 
with two different shapes of sSMC (12-Wpks-4, 12-Wpks-
159, [44]) or two isochromosomes 12p (12-Wpks-174 [44]) 
are also reported.  
  In isochromosome 18p syndrome mosaicism is rather 
rare. But also here exceptional cases are known having the 
full clinical phenotype but normal karyotype in some of the 
body cells (18-Wi-42, 18-Wi-153, 18-Wi-154, 18-Wi-157 
[44]). In case 18-Wi-41 [44] the i(18p) was derived from the 
clinically normal mother; the latter had the i(18p) in only 4% 
of her peripheral blood cells. Also, an interesting case of 
somatic mosaicism is 18-Wi-158 [44] showing prenatally an 
i(18p) in 35% of the amnion cells but postnatal only normal 
cells in peripheral blood, being a normal child.  
  To the best of our knowledge no mosaic cases are known 
by now for Emanuel-syndrome (ES) [44]. Also in cat-eye-
syndrome (CES) mosaicism is rather rare. sSMC derived 
from chromosome 22 having two different shapes were seen 
in CES (22-Wces-2 [44]) or minimal mosaicism with a nor-
mal cell line (22-Wces-3-03, 22-Wces-5, 22-Wces-5-119 
[44]).  
  Overall, somatic mosaicism is, compared to other sSMC 
derived from the corresponding chromosomes, over-
represented in PKS (100% vs. 79%) and under-represented 
in i(18p) syndrome (4% vs. 67%), ES (0% vs. 32%) and CES 
(3% vs. 32%). 
SOMATIC MOSAICISM IN PRADER-WILLI- AND 
ANGELMAN-SYNDROME WITH sSMC 
  26 sSMC cases with Prader-Willi-syndrome (PWS) and 7 
with Angelman-syndrome (AS) can be found in the literature 
[44]. 15 of these are PWS (58%) while only 1 of these AS 
cases (14%) is mosaic with respect to sSMC presence [44]. 
As the corresponding syndromes were caused either by uni-
parental disomy or microdeletion the sSMC presence has no 
direct influence on the clinical outcome; neither has mo-
saicism. 
SOMATIC MOSAICISM IN sSMC PRESENT IN 
STRUCTURALLY ABNORMAL BUT BALANCED 
KARYOTYPE  
  Another rare cytogenetic variant of sSMC presence is 
that of a structurally abnormal but balanced karyotype 
(McClintock mechanism) [48]. Such cases can either be 
connected with a neocentromere formation (see section be-
low) or both the derivatives share the available centromeric 
alpha-satellite sequences. If in such case mosaicism appears, 
i.e. loss of the sSMC, relevant genetic material is lost and 
this leads normally to clinical problems as described for the 
following cases: 03-W-p11/1-1, 04-W-p15.3/1-1, 04-W-
p12/1-1 [44]. If no or only very low grade mosaicism is pre-
sent the carrier of such a karyotype can be completely nor-
mal (e.g. 02-O-p12/1-1, 06-O-p22.3/1-1, 06-O-p22.3/1-1, 
08-O-p11.1/2-1, 12-U-4, 17-O-p11.2/2-1, mother of 19-W-
10/2-1, mother of 22-W-q11.2/2-1 [44]).  
SOMATIC MOSAICISM IN NEOCENTRIC sSMC 
  For mosaicism in neocentric sSMC formed by McClin-
tock mechanism, [48] the same holds true, like for the 
aforementioned centric sSMC present in structurally abnor-
mal but balanced karyotype. If balanced and no or only 
minimal mosaicism is present, the carriers of such a chromo-
somal condition are clinically normal. If the neocentric 
sSMC is lost in a higher percentage of the body cells this has 
an adverse prognosis. 
  In general, in at least around 50% of the cases with a 
neocentric sSMC somatic mosaicism is observable (Table 4). 
Strikingly, as in centric sSMC, mosaicism is more frequent 
in non-acrocentric derived compared to acrocentric derived 
ones (58% vs. 24%).  
SOMATIC MOSAICISM IN sSMC PRESENT IN NU-
MERICALLY ABNORMAL BASIC KARYOTYPES 
  As above mentioned, sSMC can appear in a numerically 
normal basic karyotype of 46 chromosomes, but also in 
numerically abnormal basic karyotypes [42]. Up to now, 
sSMC are reported additionally to a basic karyotype 45, X (= 
Turner syndrome), 47, XXY (= Klinefelter syndrome), 47, 
XXX (triple-X syndrome) and 47, +21 (Down syndrome) 
[44, 49-51]. 
  542 cases are available in the literature with a basic 
karyotype typical for Turner syndrome and an additional 
sSMC, i.e. 46,X,+mar [44, 49]. Only 73 of these are reported 
without mosaicism; thus, 76% of these Turner syndrome 
cases are mosaic [44]. 
  Only three cases, each of them are known by now with 
Klinefelter- or triple-X syndrome and an additional sSMC. 
Concerning the Klinefelter-syndrome two cases of those are 
mosaic (07-U-6, 0X-U3) and one not (09-U5) [44]. For tri-Somatic Mosaicism in Cases with Small Supernumerary Marker  Current Genomics, 2010, Vol. 11, No. 6    437 
ple-X syndrome the same holds true: cases 09-U16 and 14-
O-q11.1/1-5 are mosaic, case 14-U-5 is not [44].  
  For sSMC, at present additionally to a trisomy 21 
(Down-syndrome), information on mosaic status is available 
in 16 cases; 7 of those (44%) have somatic mosaicism with a 
cell line 47, +21 without sSMC [44].  
  Overall, mosaicism is a frequent finding when an sSMC 
is present additionally to a numerically abnormal basic 
karyotype.  
SOMATIC MOSAICISM IN sSMC AND THE RE-
SULTING PITFALLS 
  Summarizing all above mentioned groups, 1626 of 3124 
cases with sSMC (52%) present with somatic mosaicism. 
Even though, expressed to a different extent in various sub-
groups, mosaicism is something to be considered in at least 
every second such case. However, if a specific genetic im-
balance caused by an sSMC is known to be harmful, in the 
overwhelming majority of the cases there is no influence of 
the grade of somatic mosaicism detectable in peripheral 
blood or amnion cells and the observed clinical effects. This 
seems to be due to the fact that the mosaicism rate in differ-
ent human tissues is practically not predictable and very 
variable [52]. Only in exceptional cases the presence of spe-
cific sSMC with known adverse prognosis was reported 
which did not lead to clinical problems due to low somatic 
mosaicism; examples are 07-W-p10/1-1, 15-O-q13/1-1, 15-
O-q13/1-2, 15-O-q13/2-1, 15-O-q13/3-1, 15-O-q13.1/1-1, 
22-O-q11.21/4-2, 22-O-q11.21/4-3, 22-O-q11.21/5-1 [44]. 
Even though rare, this knowledge is extremely important for 
prenatal counseling. 
  Knowing that somatic mosaicism happens in ~50% of the 
cases with sSMC, array-CGH studies cannot be offered as a 
screening test to reliably detect this kind of chromosomal 
aberration. On the one hand, low level mosaic cases and on 
Table 4.  Mosaicism in Cases with Neocentric sSMC 
sSMC derived from chromosome  Number of cases with mosaicism   Percentage of cases with mosaicism  
1 3/5  60% 
2 3/4  75% 
3 10/11  91% 
4 1/1  100% 
5 0/1  0% 
6 1/2  50% 
7 1/1  100% 
8 7/9  77% 
9 1/3  33% 
10 1/2  50% 
11 0/2  0% 
12 2/3  75% 
13 5/14  56% 
14 1/1  100% 
15 2/19  11% 
16 1/1  100% 
17 0/1  0% 
18 1/1  100% 
19 n.a.  n.a. 
20 0/1  0% 
21 n.a.  n.a. 
22 n.a.  n.a. 
X 0/1  0% 
Y 0/1  0% 
overall 40/86  47% 
acrocentric 8/34  24% 
non-acrocentric 32/55  58% 438    Current Genomics, 2010, Vol. 11, No. 6  Liehr et al. 
the other hand, cryptic mosaics are missed. Thus, cytogenet-
ics is still the gold-standard to detect any kind of chromoso-
mal aberration, which then, in further steps can be character-
ized by molecular (cyto-) genetic approaches.  
  Interestingly, acrocentric and non-acrocentric derived 
sSMC are differently susceptible to mosaicism; acrocentric 
derived ones are hereby the more stable ones. This holds true 
for centric and neocentric sSMC, and an explanation is there-
fore at present not available.  
CONCLUSION 
  Somatic mosaicism is a feature of the human body, 
which has to be considered much more than up to now in 
future. It is known as a fact, but not understood why man 
with age (in peripheral blood) develops something like a 
‘Turner-syndrome-mosaic’ 46,XY/45,X. Similarly, in cases 
with sSMC it is known since years, that PKS patients lose 
the i(12p) in peripheral blood or that some inv dup(15) 
sSMC are stable and cytogenetically identical ones in an-
other carrier are not. For all these facts to the best of our 
knowledge, no studies were undertaken to come closer to an 
understanding of these phenomena. Here we present, some 
kind of starting point for such studies, for the first time a 
detailed ‘mosaicism map’ for the different subtypes of 
sSMC. 
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